TipRanks
Agios Pharma (MX:AGIO)
:AGIO
Mexico Market
AGIO
Agios Pharma
RESEARCH TOOLSreports

Agios Pharma (AGIO) Stock News & Sentiment

1 Followers
Agios Pharmaceuticals Signals Momentum Amid Ongoing Losses
Premium
Company Announcements
Agios Pharmaceuticals Signals Momentum Amid Ongoing Losses
1M ago
AGIO
Agios: Buy Rating Reiterated on Strong AQVESME Uptake and Pipeline Progress, Price Target Maintained at $46
Premium
Ratings
Agios: Buy Rating Reiterated on Strong AQVESME Uptake and Pipeline Progress, Price Target Maintained at $46
2M ago
AGIO
Agios: Strong Mitapivat Launch and Growing Patient Uptake Drive Confident Buy Rating
Premium
Ratings
Agios: Strong Mitapivat Launch and Growing Patient Uptake Drive Confident Buy Rating
2M ago
AGIO
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AGIO
Agios Pharmaceuticals: Buy Rating Reaffirmed with Unchanged $46 Price Target on Mitapivat Sickle Cell Catalyst and AQVESME Thalassemia Launch Momentum
Premium
Ratings
Agios Pharmaceuticals: Buy Rating Reaffirmed with Unchanged $46 Price Target on Mitapivat Sickle Cell Catalyst and AQVESME Thalassemia Launch Momentum
2M ago
AGIO
Mitapivat’s Priority Review in Sickle Cell Disease Supports First-in-Class 2026 Launch, Long-Term Growth; Buy Rating and $54 Price Target Maintained
Premium
Ratings
Mitapivat’s Priority Review in Sickle Cell Disease Supports First-in-Class 2026 Launch, Long-Term Growth; Buy Rating and $54 Price Target Maintained
3M ago
AGIO
Agios Pharma Shareholders Expand Equity Plan, Reelect Directors
Premium
Company Announcements
Agios Pharma Shareholders Expand Equity Plan, Reelect Directors
3M ago
8K
AGIO
More MX:AGIO News >

AGIO News on the Web

FARALLON CAPITAL MANAGEMENT LLC Adds to Agios Pharmaceuticals Inc (AGIO) Stake -- Shares Trade ...
GuruFocus News
Bullish
Lynx1 Capital Management LP Acquires Additional Shares in Precision BioSciences Inc
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO) and Imunon (IMNN)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO), Revolution Medicines (RVMD) and Airsculpt Technologies (AIRS)
TipRanks News
Bullish
Agios Pharmaceuticals: Buy Rating Reaffirmed with Unchanged $46 Price Target on Mitapivat Sickle Cell Catalyst and AQVESME Thalassemia Launch Momentum
TipRanks News
Bullish
Agios Pharmaceuticals (AGIO) Ends Development of Sickle Cell Drug Tebapivat
GuruFocus News
Neutral
Agios Pharmaceuticals price target lowered to $52 from $54 at H.C. Wainwright
TipRanks News
Neutral
Morning Movers: Equifax sinks following second quarter earnings
TipRanks News
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average3.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:AGIO’s Media Buzz Sentiment?
Currently, no data Available
What is MX:AGIO’s weekly average amount of articles?
In an average week, 3.75 articles about MX:AGIO are published.
    What is MX:AGIO’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CRLCharles River Labs
    DFTXDefinium Therapeutics
    AMRXAmneal Pharmaceuticals
    IOVAIovance Biotherapeutics
    HITIHigh Tide
    Showing the stocks with the most bullish news sentiment over the past week